December 03, 2024

Roivant Ends Lung Drug After Trial

Reuters

November 27, 2024

Key Risk Factors for SARD-ILD Progression

Conexiant

November 25, 2024

SCOTUS Sidesteps Tobacco Warning Case

Reuters

November 13, 2024

Is COPD Set to Affect 600M Globally?

GOLD 2025 highlights new pathways and advanced COPD therapies like ensifentrine and dupilumab to reduce exacerbations and address emerging COPD phenotypes.

Conexiant

November 13, 2024

Systemic Sclerosis Lung Disease: Timing Matters Less

Although interstitial lung disease typically develops early in systemic sclerosis, a study of 969 patients revealed that ILD presenting after 7 years of disease showed identical progression rates and severity patterns as early-onset cases, challenging traditional monitoring assumptions.

Conexiant

November 11, 2024

Still's Disease: New EULAR/PReS Recommendations

Idiopathic arthritis and adult-onset Still’s disease now recognized as one condition.

Conexiant

November 06, 2024

Lung Cancer: Most High-Risk Patients Not Getting Screened

Despite having lung conditions or cancer history, over 70% of high-risk patients never discussed lung cancer screening with their clinicians.

Conexiant

July 26, 2024

EHR Use Disparities: Female vs. Male Surgeons

A recent study published in JAMA Network Open reveals gender differences in electronic health record (EHR) usage among surgeons, with female surgeons writing significantly longer progress notes than their male counterparts.

Conexiant

July 26, 2024

Healing and Owing: U.S. Health Workers' $150 Billion Debt Dilemma

A new study exposes the alarming levels of medical and educational debt burdening U.S. health care workers, with debt disproportionately affecting women, Black workers, and those in lower-paying fields.

Conexiant